Study record

Reduced Circulating MOTS-c Levels in Hashimoto's Thyroiditis Reflect Integrated Autoimmune and Metabolic Dysregulation: A Cross-Sectional Study

Sonay HO, Duran EN, Algemi M et al. · J Clin Med · 2026

Human obs.Endogenous MOTS-c measuredEvidence tier B

What this study reported

Measured lower circulating MOTS-c in patients with Hashimoto's thyroiditis than in matched controls, with inverse correlations with body mass index, fasting glucose, HbA1c, HOMA-IR, thyroid-stimulating hormone, C-reactive protein and thyroid autoantibodies. Reported that Hashimoto's thyroiditis and HOMA-IR were independent determinants of lower MOTS-c in regression analysis.

Limitations

Cross-sectional design cannot establish direction; single-centre sample measured by ELISA at one time point; medication and iodine status largely unaccounted for beyond levothyroxine use.

Study record

Annotated fields for this study
Study modelHuman observational
Substance studiedEndogenous MOTS-c measuredNaturally occurring MOTS-c was measured; nothing was given.
Specieshuman
System studiedPatients with Hashimoto's thyroiditis and age- and sex-matched healthy controls; circulating MOTS-c
Populationadults with Hashimoto's thyroiditis and age- and sex-matched healthy controls
DesignCross-sectional case-control study
Sample size as reported180 participants (90 with Hashimoto's thyroiditis, 90 controls)
Control groupage- and sex-matched healthy controls
Route (data field only)Not reported
Endpoints measuredcirculating MOTS-c; HOMA-IR and fasting glucose; HbA1c and body mass index; thyroid-stimulating hormone and thyroid autoantibodies; C-reactive protein
Pathways measuredInsulin & glucose handling · Inflammation
Research areasMetabolic · Inflammation & immunity · Mitochondrial biology
Evidence tierB — Other human study
Publication typesJournal Article

Appraisal

Each dimension is recorded separately and never combined into a single score. A study can be well controlled and still tell you little about people.

Relevance to MOTS-c
Direct
Model applicability
Human
Sample size
Adequate
Controls
Appropriate
Outcome validity
Validated biomarker
Support for its own conclusion
Moderate

Provenance

  • Bibliographic fields retrieved from PubMed E-utilities efetch (title, journal, date, authors, DOI) on 2026-11-11.
  • Annotated from the published abstract.
  • Editorial review: approved (2026-11-11).
  • Classification follows the site methodology; the record describes the study, not what MOTS-c does in people.